International Oncology Services Private Limited (IOSPL) recently announced that it signed up a deal with Dr. L. H. Hiranandani Hospital, Mumbai to set up a state-of-the-art  cancer centre called ‘International Oncology Centre.’ This will be a comprehensive centre with Radiation Oncology, Medical Oncology, Surgical Oncology and Bone Marrow Transplant. Dedicated to serving society with the help of latest technological upgradations in the field of cancer research and treatment, the centre is a path breaking collaboration between International Oncology Services (IOSPL) and Dr L.H. Hiranandani Hospital, thereby becoming the only hospital in Maharashtra to initiate such a business model.

Dr L H Hiranandani Hospital has signed an MoU with IOSPL which has a close association with the Albert Einstein Cancer Centre. This association is setting a new paradigm in the treatment of Cancer and presenting a new emerging business model in the field of healthcare.

IOSPL has a similar model already with Fortis Healthcare Limited in the NCR area.Pradeep K Jaisingh, MD& CEO,IOSPL,informs that,’A collaboration of this nature presents a great opportunity to leverage the combined strengths of the two organisations to build a world class cancer centre in Mumbai. We are very confident that the centre will make a significant positive impact in the field of cancer care in Maharashtra.’

Says Dr Sujit Chatterjee, CEO, Dr L H Hiranandani Hospital Powai, ‘This collaboration proves that the expertise in US comes home bridging the gap in technologies. This is the way forward for all future Indian healthcare programs. The process of outsourcing is only going to contain healthcare costs. It will also raise the bar in delivery of healthcare as those who come in as partners are focused have established themselves as excellent in their field. This country is going to see more of strategic and functional outsourcing.’

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.